FindTrial
Sign In

Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

Efficacy Comparative Study Between Tears Again®, o Opticol® e o Optive® in Clinical and Symptomatology Treatment of Dry Eye Syndrome in Contact Lens Wearers and/or Computers Users

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00893243
Enrollment
27
Registered
2009-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2009-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Brief summary

Primary Purpose: * To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive® Secondary Purpose: * Subjective evaluation of symptomatology * Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Interventions

None listed

Sponsors

Hospital de Sao Sebastiao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed Consent signed * Age \>18 years and \< 55 years * Daily wearer of soft contact lens and/or daily (\> 4 hours/day) computer user

Exclusion criteria

* Dry eye Syndrome other than of evaporative etiology, according to DEWS * Ocular or systemic disease that can affect the normal tear film * Pregnancy or pregnancy risk (no contraceptive method), lactation

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026